SCHEMBL23770514

SCHEMBL23770514

CC1(C)c2ccccc2-c2c(-c3nc(-c4ccc(-c5cccc6ccccc56)cc4)nc(-c4ccc(-c5cccc6c5sc5ccccc56)cc4)n3)cccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.40
PARP14 Q460N5 1/20 0.34
ENPP3 O14638 1/20 0.33
ENPP1 P22413 1/20 0.33
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
F9 P00740 1/20 0.31
PRKDC P78527 3/20 0.31
SLC9A1 P19634 2/20 0.31
MAPT P10636 2/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
TP53 P04637 1/20 0.30
HPGD P15428 1/20 0.30
TSHR P16473 1/20 0.30
NFKB1 P19838 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20465203 0.96 ALOX5 (0.43) ALOX5PARP14PRKDCSLC9A1MAPT
SCHEMBL20465224 0.96 ALOX5 (0.43) ALOX5PARP14PRKDCSLC9A1MAPT
SCHEMBL24682155 0.95 ALOX5 (0.43) ALOX5PARP14PRKDCSLC9A1MAPT
SCHEMBL23770304 0.94 ALOX5 (0.42) ALOX5PARP14ENPP1F9PRKDC
SCHEMBL24682156 0.94 ALOX5 (0.42) ALOX5PARP14PRKDCMAPTPIK3CD
SCHEMBL23770311 0.93 ALOX5 (0.41) ALOX5PARP14F9PRKDCSLC9A1
SCHEMBL23770420 0.93 ALOX5 (0.41) ALOX5PARP14F9PRKDCSLC9A1
SCHEMBL23770403 0.93 ALOX5 (0.41) ALOX5PARP14F9PRKDCSLC9A1
SCHEMBL23770423 0.92 ALOX5 (0.40) ALOX5PARP14F9PRKDCSLC9A1
SCHEMBL23770469 0.91 ALOX5 (0.37) ALOX5PARP14F9PRKDCSLC9A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230123170-A1 COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-20 US disclosed
WO-2021162122-A1 COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230123170-A1 COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND L1CAM, LEF1, CCNL2 ALOX5 1852/4885PARP14 2731/4885ENPP3 2948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.